Densitometry funding again promoted on Hill

Article

Congress may consider legislation this session calling for Medicarereimbursement of bone densitometry procedures. Sponsors of theMedicare Bone Mass Measurement Coverage Act of 1991 and a companionosteoporosis research bill face an uphill battle, however,

Congress may consider legislation this session calling for Medicarereimbursement of bone densitometry procedures. Sponsors of theMedicare Bone Mass Measurement Coverage Act of 1991 and a companionosteoporosis research bill face an uphill battle, however, aspressure grows to keep a lid on Medicare expenditures.

Rep. Olympia Snowe (R-ME) and Sen. John Glenn (D-OH) introducedthe reimbursement bill last year, but it did not reach a vote.They reintroduced the legislation in February.

Legislation authorizing reimbursement of densitometry exams--evenat $50 each--could raise Medicare costs by billions of dollars.That may be a hard pill for Congress to swallow, given the politicalreaction against rising health-care costs, said Joel B. Weinstein,vice president of marketing for Hologic, a densitometry vendor(see story, page 2).

"I don't see that this is the year people are ready tospend $7 billion more on medical reimbursement," he said.

The number of congressional sponsors of the legislation hasincreased this year, however, which is a positive sign, he said.

Even if Congress authorizes reimbursement of densitometry exams,there is no assurance that the medical community will enthusiasticallyadopt the procedures, said Joel Blank, vice president of marketingfor Norland of Fort Atkinson, WI.

"Reimbursement is a bit of a red herring. It is a result,not a cause--a result of the fact that there are a limited numberof (osteoporosis) therapies available in this country and a lackof consensus in the medical community," he said.

The National Osteoporosis Foundation and other supporters ofosteoporosis prevention and treatment are making headway in educatingdoctors, however. Attendance at conferences focusing on osteoporosisis increasing, he said.

There is also a good chance that a report due in July fromthe Office of Technology Assessment (OTA), an advisory body toCongress, may provide a favorable review of dual-energy x-rayabsorptiometry (DEXA) and other bone densitometry technologies,Weinstein said.

BRIEFLY NOTED:

  • The Health Care Financing Administration (HCFA) is closeto signing off on regulations instituting cost-effectiveness asa criterion for Medicare reimbursement, according to a reportin the New York Times. The agency confirmed that these regulationsare being finalized, but would not provide an expected date ofcompletion.

HCFA first proposed the use of cost-effectiveness as part ofa "reasonable and necessary" criterion for reimbursementover two years ago (SCAN 3/15/89).

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.